Revolution Medicines, Inc.
RVMDW- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001628171
In the last 90 days, Revolution Medicines, Inc. insiders filed 0 open-market purchases and 17 sales; 22 institutions reported holding it in 13F filings for Q2 2026, worth $93.0M in total; no superinvestor holds it.
Other share classesRVMD
13F holders, Q4 2023
Institutional positions in Revolution Medicines, Inc. as of Dec 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 22
- +22 vs. Q3 2023
- Shares held
- 4.93M
- +4.93M vs. Q3 2023
- Total value
- $1.62M
- +$1.62M vs. Q3 2023
- New holders
- 22
- 0 more added
- Sold out
- 0
- 0 more reduced
Compare with Q3 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting RVMDW on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 22 | $93.0M |
| Q1 2026 | 23 | $17.8M |
| Q4 2025 | 24 | $8.15M |
| Q3 2025 | 22 | $2.40M |
| Q2 2025 | 23 | $2.12M |
| Q1 2025 | 24 | $298.5K |
| Q4 2024 | 24 | $1.31M |
| Q3 2024 | 25 | $654.7K |
| Q2 2024 | 25 | $623.7K |
| Q1 2024 | 24 | $1.21M |
| Q4 2023 | 22 | $1.62M |
| Q3 2023 | 0 | $0 |
| Q2 2023 | 0 | $0 |
| Q1 2023 | 0 | $0 |
| Q4 2022 | 0 | $0 |
| Q3 2022 | 0 | $0 |
| Q2 2022 | 0 | $0 |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q4 2023
Shares, value and share of portfolio for each institution holding Revolution Medicines, Inc.; share changes are against Q3 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Advisor Group Holdings, Inc. | 4 | $1 | 0.00% | +4 | New |
| TD Waterhouse Canada Inc. | 448 | $133 | 0.00% | +448 | New |
| UBS Group AG | 971 | $320 | 0.00% | +971 | New |
| Texas Yale Capital Corp. | 10,000 | $3.30K | 0.00% | +10,000 | New |
| TD Asset Management Inc | 40,636 | $13.4K | 0.00% | +40,636 | New |
| Wolverine Asset Management LLC | 70,349 | $23.2K | 0.00% | +70,349 | New |
| Weiss Asset Management LP | 73,640 | $24.3K | 0.00% | +73,640 | New |
| DLK Investment Management, LLC | 77,000 | $25.4K | 0.01% | +77,000 | New |
| Magnetar Financial LLC | 119,289 | $39.4K | 0.00% | +119,289 | New |
| Farallon Capital Management, L.L.C. | 120,085 | $39.6K | 0.00% | +120,085 | New |
| Davidson Kempner Capital Management LP | 150,000 | $49.5K | 0.00% | +150,000 | New |
| Sculptor Capital LP | 178,107 | $61.0K | 0.00% | +178,107 | New |
| Cowen and Company, LLC | 199,900 | $66.0K | 0.00% | +199,900 | New |
| Bleichroeder LP | 200,000 | $66.0K | 0.01% | +200,000 | New |
| Perceptive Advisors LLC | 250,000 | $82.5K | 0.00% | +250,000 | New |
| Soros Capital Management LLC | 364,824 | $120.4K | 0.09% | +364,824 | New |
| Adage Capital Partners GP, L.L.C. | 500,000 | $165.0K | 0.00% | +500,000 | New |
| Walleye Capital LLC | 595,986 | $196.7K | 0.00% | +595,986 | New |
| Price T Rowe Associates Inc | 608,474 | $201.0K | 0.00% | +608,474 | New |
| D. E. Shaw & Co., Inc. | 1,347,439 | $444.7K | 0.00% | +1,347,439 | New |
| CSS LLC | 11,881 | – | – | +11,881 | New |
| Boothbay Fund Management, LLC | 8,144 | – | – | +8,144 | New |